Promakhos Therapeutics is excited to announce it will participate as a new Venture Team for the Spring 2021 season in the Harvard Innovation Labs Venture Program, a 3 month pre-accelerator program offered by Harvard University through the Harvard Business School. Promakhos Therapeutics will be part of the Build It track for Health & Sciences. The Harvard Venture Program provides Promakhos Therapeutics with a supportive community of business experts, mentors and advisors through the Harvard Innovation Labs ecosystem.
The program also offers access to key resources and competitive, non-dilutive funding opportunities. Most importantly, the program sets up the trajectory for Promakhos Therapeutics to compete in the Harvard Innovation Labs Spring 2021 President's Innovation Challenge and the Harvard Allston Venture Fund.
For more information about the Harvard Venture program-associated funding opportunities please visit: